IOLCP — IOL Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹28.62bn
- IN₹27.62bn
- IN₹20.79bn
- 67
- 40
- 88
- 76
Annual cashflow statement for IOL Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,714 | 2,249 | 1,887 | 1,817 | 1,380 |
Depreciation | |||||
Non-Cash Items | -118 | -101 | -17.5 | -27.9 | 78.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,188 | -1,650 | -1,108 | 483 | -392 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,798 | 931 | 1,223 | 2,901 | 1,786 |
Capital Expenditures | -1,082 | -1,533 | -2,118 | -2,742 | -2,136 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2,090 | 331 | 918 | 829 | 594 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,173 | -1,202 | -1,200 | -1,913 | -1,542 |
Financing Cash Flow Items | -57 | -81.1 | -164 | -161 | -148 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -583 | -16.4 | -41.1 | -925 | 460 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 42.5 | -288 | -18.4 | 63 | 705 |